More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$2.39B
EPS
4.89
P/E ratio
19.5
Price to sales
1.28
Dividend yield
1.895%
Beta
0.904683
Previous close
$97.43
Today's open
$96.50
Day's range
$96.50 - $97.66
52 week range
$65.51 - $100.48
show more
CEO
Patrick S. Williams
Employees
2450
Headquarters
Englewood, CO
Exchange
Nasdaq Global Select
Shares outstanding
24631047
Issue type
Common Stock
Materials
Chemicals
Innospec Schedules Third Quarter 2026 Earnings Release and Conference Call
ENGLEWOOD, Colo., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced that it will release third quarter 2026 earnings results on Tuesday, November 3, 2026 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, November 4, 2026, at 9:00 a.m. ET.
GlobeNewsWire • Oct 5, 2026

Innospec (IOSP) Up 2% Since Last Earnings Report: Can It Continue?
Innospec (IOSP) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research • Sep 3, 2026

4 Diversified Chemical Stocks to Gain Amid Stable End-market Demand
The Zacks Chemicals Diversified is expected to benefit from healthy demand across major end-use markets and the end of destocking activities. APD, DD, AVNT and IOSP are set to gain from strategic actions and demand recovery.
Zacks Investment Research • Aug 18, 2026

Innospec: Topline Is Growing As Expected
With the oilfield segment leading topline growth, even more growth should be expected as the adoption of DRA expands and the firm re-enters the Mexico market. In Q2 of 2026, revenue grew 12%, beating estimates by $34.17 million. The firm is now in a better financial position to command a higher sales multiple. The Performance chemical segment still experiences volume declines, raising concerns about the firm over investing by adding 10% capacity in a weak market.
Seeking Alpha • Aug 12, 2026

IOSP's Q2 Earnings Surpass Estimates on Broad-Based Growth
Innospec's Q2 earnings beat estimates as all three businesses delivered revenue growth, while a debt-free balance sheet supports further investment.
Zacks Investment Research • Aug 7, 2026

Is Innospec (IOSP) Stock Outpacing Its Basic Materials Peers This Year?
Here is how Innospec (IOSP) and Ingevity (NGVT) have performed compared to their sector so far this year.
Zacks Investment Research • Aug 7, 2026

Innospec Q2 Earnings Call Highlights
Innospec NASDAQ: IOSP reported higher second-quarter revenue and net income as all three operating segments posted double-digit sales growth and operating-income gains, while the company continued repair and optimization work at its North Carolina Performance Chemicals facilities.
MarketBeat • Aug 5, 2026

Innospec Inc. (IOSP) Q2 2026 Earnings Call Transcript
Innospec Inc. (IOSP) Q2 2026 Earnings Call Transcript
Seeking Alpha • Aug 5, 2026

Innospec Reports Second Quarter 2026 Financial Results
Strong contributions from all businesses with revenues up 12 percent and operating income up 16 percent
GlobeNewsWire • Aug 4, 2026

Innospec (IOSP) Tops Q2 Earnings and Revenue Estimates
Innospec (IOSP) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $1.26 per share a year ago.
Zacks Investment Research • Aug 5, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Innospec Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.